BioXcel Therapeutics, Inc(NASDAQ:BTAI) 
BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology in the United States. The company is involved in developing BXCL501, a sublingual thin film formulation of adrenergic re...
Website: http://www.bioxceltherapeutics.com
Founded: 2017
Full Time Employees: 40
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.73
H 1.73
L 1.53
C 1.63
V 241,955
10EMA 1.63
20EMA 1.63
60EMA 1.63
120EMA 1.63
250EMA 1.63